CoChat

Clonazepam for the Treatment of Panic Disorder

E. Nardi, Antonio, Machado, Sergio, Ferreira Almada, Leonardo, Paes, Flavia, Cardoso Silva, Adriana, Jose Marques, Ricardo, Amrein, Roman, C. Freire, Rafael, Martin-Santos, Rocio, Cosci, Fiammeta, E. Hallak, Jaime, A. Crippa, Jose, Arias-Carrion, Oscar · 2013 · Current Drug Targets
Cited by 40

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

Abstract

Clonazepam was initially licensed as an anti-epileptic agent, but its use in a wide variety of psychiatric conditions, including panic disorder (PD) has now been well established. This overview evaluates the current role of clonazepam alone or in combination with antidepressants and/or behavioral therapy in the treatment of PD. We review the data establishing the use of clonazepam in the treatment of PD as well as new information, particularly confirmation of longterm efficacy and safety. We also discuss a regimen for safely tapered withdrawal of clonazepam, the characteristics of the respiratory subtype of PD, and CO2-induced panic attacks as a diagnostic measure and predictor for therapeutic success. It has been shown that panic attacks can more readily be induced by CO2 in PD patients with the respiratory subtype than those with the non-respiratory subtype. More than 25 years after the first report of efficacy in PD in 1984, clonazepam, alone or combined with selective serotonin reuptake inhibitors (SSRIs) and/or behavioral therapy, remains an important therapeutic modality for the management of PD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2174/1389450111314030007

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 13 references

Cited by

See all 40

Metadata

Authors
E. Nardi, A., Machado, S., Ferreira Almada, L., Paes, F., Cardoso Silva, A., Jose Marques, R., Amrein, R., C. Freire, R., Martin-Santos, R., Cosci, F., E. Hallak, J., A. Crippa, J., & Arias-Carrion, O.
Venue
Current Drug Targets
Published
2013-01-01
Volume
14
Issue
3
Pages
353-364
ISSN
1389-4501 (ISSN-L)
OpenAlex
W2166964750
Cited by
40
References
13
FWCI
3.50
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Clonazepam for the Treatment of Panic Disorder. https://app.cochat.ai/papers/10.2174/1389450111314030007
The paper
E. Nardi, A., Machado, S., Ferreira Almada, L., Paes, F., Cardoso Silva, A., Jose Marques, R., Amrein, R., C. Freire, R., Martin-Santos, R., Cosci, F., E. Hallak, J., A. Crippa, J., & Arias-Carrion, O. (2013). Clonazepam for the Treatment of Panic Disorder. Current Drug Targets. https://doi.org/10.2174/1389450111314030007

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.